SWOT Analysis for VYNE Therapeutics Inc

Promoter decreasing their shareholding
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining Revenue every quarter for the past 2 quarters
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Decreased Shareholding in Past Month
Red Flags: Weakening Technicals and Share Price Decline
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter

VYNE Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats